Literature DB >> 2902540

Psychopharmacological effects in the radial-arm maze.

E D Levin1.   

Abstract

The radial-arm maze (RAM) has become a very widely used method for assessing spatial memory in rodents. It has proven to be quite useful in the investigation of the effects of a variety of pharmacological manipulations on spatial memory. The cholinergic system has been found to be crucial for accurate RAM performance. Blockade of either muscarinic or nicotinic receptors impairs performance. Other transmitter systems such as dopamine and the opiates have also been found to be involved with the maintenance of accurate RAM performance. This test has been found to be sensitive to the effects of a variety of toxicants given either in adulthood or during development. These findings provide a background for the assessment of the effects of novel substances on RAM performance as well as the basis for the further understanding of the neural substrates of memory.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902540     DOI: 10.1016/s0149-7634(88)80008-3

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  20 in total

1.  Delayed-non-match-to-sample performance in the radial arm maze: effects of dopaminergic and gabaergic agents.

Authors:  J J Chrobak; T C Napier
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs.

Authors:  S R McGurk; E D Levin; L L Butcher
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

4.  High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors.

Authors:  John McNeish; Marsha Roach; John Hambor; Robert J Mather; Laura Weibley; John Lazzaro; Justin Gazard; Jacob Schwarz; Robert Volkmann; David Machacek; Steve Stice; Laura Zawadzke; Christopher O'Donnell; Raymond Hurst
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

5.  Tyrosine ameliorates a cold-induced delayed matching-to-sample performance decrement in rats.

Authors:  D Shurtleff; J R Thomas; S T Ahlers; J Schrot
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.

Authors:  R P Dennes; J C Barnes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.

Authors:  Rosa Ayesa-Arriola; Jose Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; Roberto Roiz-Santiáñez; Obdulia Martínez-García; Jose Sánchez-Moreno; Rafael Tabarés-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

8.  Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

Authors:  T Skarsfeldt
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

9.  Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.

Authors:  M Magnani; O Pozzi; R Biagetti; S Banfi; L Dorigotti
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.